Αρχική World News Breast Cancer Survivor Comes First Woman In The World To Give Birth...

Breast Cancer Survivor Comes First Woman In The World To Give Birth After Freezing Lab-Matured Eggs

A French infant named Jules is the first in the world to be born using a method called in vitro maturation (IVM) followed by vitrification. His mother is a breast cancer survivor who became infertile after chemotherapy treatment.In IVM, eggs are matured after they’ve been extracted from the mother, when they’re outside the body. Babies have been born as a result of IVM before, but only in cases where the eggs were immediately fertilized and implanted back into the patient.In this case, the in vitro maturation was followed by a process called vitrification, which uses liquid nitrogen to freeze the eggs very quickly to lower the chances of ice crystals forming and damaging the cell. It’s the first successful case of IVM followed by vitrification.Photo: Adobe Stock/frentaPrevious research published in 2018 from the University of Edinburgh found that female cancer survivors were 38% less likely to become pregnant than women who had not faced a cancer diagnosis. Women with breast cancer are some of the worst affected.IVM could be a game-changer for young breast cancer patients because it doesn’t require them to get hormone injections. IVF, which is a much more widely used option for women struggling with fertility because it has a higher success rate, requires the mother to get hormone injections to pump up ovulation and help the eggs mature while they’re still inside the body.However, for cancer patients and cancer survivors — as well as women with polycystic ovarian syndrome (PCOS) and women with other reproductive issues — undergoing hormone injections just isn’t a safe or feasible option. Plus, for cancer patients, undergoing weeks of hormone treatments could delay their potentially life-saving cancer treatment.Photo: Adobe Stock/pinkeyesThe study was published in the journal Annals of Oncology and led by doctors from Antoine Béclère University Hospital near Paris.The patient, who was not named in the study, was diagnosed with breast cancer at age 29. She was offered two options for saving her fertility: ovarian tissue cryopreservation or IVM.Ovarian tissue cryopreservation involves removing and freezing a patient’s ovarian tissue and then placing it back into the body once chemotherapy is completed. While this is a successful and effective method that doesn’t require hormone injections, it is an invasive surgery that cancer patients are sometimes hesitant to go through when they have so much other surgery and treatment to face. For some cancer patients, it also presents the possibility of transplanting cancer cells back into the body along with the healthy ovarian tissue.Photo: Adobe Stock/sinhyuThe unnamed patient in this study chose IVM, which is a much less invasive procedure and allowed her eggs to be harvested right away. Seven immature eggs were harvested from the patient and matured in a lab, outside of her body. They were then frozen using vitrification.Years later, after she had beaten cancer and was ready to have a baby, she tried at first to become pregnant on her own but found that she was infertile. So her eggs were thawed and fertilized, and then one embryo was implanted back in her womb.The pregnancy continued without any complications, and, at the age of 34, the patient gave birth to a healthy baby boy named Jules.Photo: Adobe Stock/aaalll3110Professor Michaël Grynberg is head of the Department of Reproductive Medicine and Fertility Preservation at the Antoine Béclère University Hospital. He provided the patient with fertility counseling and performed the patient’s fertility procedures, and he is the first author of the study.“Fertility preservation should always be considered as part of the treatment for young cancer patients,” Grynberg said. “Egg or embryo vitrification after ovarian stimulation is still the most established and efficient option. However, for some patients, ovarian stimulation isn’t feasible due to the need for urgent cancer treatment or some other contraindication. In these situations, freezing ovarian tissue is an option but requires a laparoscopic procedure and, in addition, in some diseases it runs the risk of re-introducing malignant cells when the tissue is transplanted back into the patient.“IVM enables us to freeze eggs or embryos in urgent situations or when it would be hazardous for the patient to undergo ovarian stimulation. In addition, using them is not associated with a risk of cancer recurrence.”Photo: Adobe Stock/Seventyfour“We are aware that eggs matured in the lab are of lower quality when compared to those obtained after ovarian stimulation,” said Grynberg. “However, our success with Jules shows that this technique should be considered a viable option for female fertility preservation, ideally combined with ovarian tissue cryopreservation as well.”This case shows a promising new way for cancer patients to preserve their fertility without having to go through hormone injections. We look forward to more success stories.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...